Sign in Pull a receipt

ARDX

ARDELYX, INC.

Biotechnology · Biotechnology

$127.55 sample

-0.74 (-0.58%) 1D

Market cap

$123.6B

Price as of

2026-10-24

Latest filing

8-K · 2026-09-10

Alerts

8

Price$127.55 +6.04% 3M daily closessample

129.34117.51

2026-07-282026-08-192026-09-102026-10-012026-10-23

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 21INSInsider sell: Chief Executive Officer
Oct 12INSInsider buy: Director
Oct 07INSInsider sell: 10% owner
Sep 29INSInsider sell: Director
Sep 23INSInsider sell: 10% owner
Sep 17INSInsider sell: General Counsel
Sep 10SECDEF 14A filed
Sep 07SEC10-Q filed

Sign up to see the real ARDX record →

Company facts

SEC EDGAR registration

Name: ARDELYX, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: +5sample, -100 to +100
Reporting currency: USD

Who is positioning in ARDX

sample

Insiders: 19 insider transactions over 90 days, net selling, $130.2M
Congress: 2 members traded over 90 days
Institutions · 13F: 31 funds hold $3.0B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$7.3B +16.7% y/y

Q4 2024Q3 2026

Inventory$4.4B +10.4% y/y

Q4 2024Q3 2026

Accounts receivable$3.4B +16.3% y/y

Q4 2024Q3 2026

Total debt$8.4B +2.8% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $104.4B -10.0% 3M
Sample peer B: $108.1B +14.1% 3M
Sample peer C: $95.3B +8.7% 3M
Sample peer D: $21.6B +3.4% 3M
Sample peer E: $27.6B +1.1% 3M